Skip to Content

TEVA B1 (Letrozole 2.5 mg)

Pill with imprint TEVA B1 is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Teva Pharmaceuticals USA Inc.

Letrozole is used in the treatment of female infertility; breast cancer; breast cancer, metastatic; breast cancer, adjuvant and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA B1

Letrozole 2.5 mg TEVA B1
Letrozole 2.5 mg TEVA B1 Front
Letrozole 2.5 mg TEVA B1 Back
Letrozole 2.5 mg TEVA B1


2.5 mg
Prescription only
Drug Class:
Aromatase inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA Inc
Inactive Ingredients:
silicon dioxide
FD&C Blue No. 2
aluminum oxide
FD&C Yellow No. 5
ferric oxide yellow
lactose monohydrate
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polyvinyl alcohol
sodium starch glycolate type A potato
corn starch
magnesium silicate
titanium dioxide
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
42291-0374 AvKare, Inc.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.